Related Experiment Video
Updated: Jun 21, 2026

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Update on childhood urinary tract infection and vesicoureteral reflux
Lorraine E Bell1, Tej K Mattoo
1Department of Pediatrics, Division of Pediatric Nephrology, McGill University Health Centre, Montreal, Quebec, Canada.
Insights
Urinary tract infections (UTIs) in children with vesicoureteral reflux (VUR) can lead to kidney damage. The RIVUR study investigates if antibiotics can prevent UTIs and protect kidneys in these young patients.
Area of Science:
- Pediatric Urology
- Infectious Diseases
- Nephrology
Background:
- Urinary tract infection (UTI) is a significant cause of bacterial infection in young children.
- Vesicoureteral reflux (VUR) is a common pediatric urologic disorder linked to UTIs and renal scarring.
- Renal parenchymal abnormalities in VUR can be noninfectious and lead to long-term complications like hypertension and renal insufficiency.
Purpose of the Study:
- To investigate the complex interplay between bacterial virulence and host defenses in pediatric renal damage.
- To evaluate the effectiveness of antimicrobial prophylaxis in preventing UTIs and subsequent renal scarring in children with VUR.
- To address the controversy surrounding optimal management of VUR and UTI due to limited evidence from randomized controlled trials.
Main Methods:
- The study focuses on the Randomized Intervention for children with VesicoUreteral Reflux (RIVUR) trial.
- This research involves well-designed studies to gather robust data on VUR and UTI management.
- The RIVUR study specifically examines the role of antimicrobial prophylaxis in children diagnosed with VUR.
Main Results:
- The abstract indicates that the RIVUR study is recently launched and aims to provide insights.
- Results regarding the efficacy of antimicrobial prophylaxis are anticipated from the ongoing RIVUR study.
- The study will contribute to understanding the long-term sequelae of VUR and associated UTIs.
Conclusions:
- Optimal management strategies for VUR and UTI in children require further investigation.
- The RIVUR study is expected to offer crucial evidence on the benefits of antimicrobial prophylaxis.
- Understanding the pathogenesis of renal damage in VUR is essential for improving patient outcomes.
Abstract:
Urinary tract infection (UTI) is a leading cause of serious bacterial infection in young children. Vesicoureteral reflux (VUR), a common pediatric urologic disorder, is believed to predispose to UTI, and both are associated with renal scarring. The complex interaction of bacterial virulence factors and host defense mechanisms influence renal damage. However, some renal parenchymal abnormalities associated with VUR are noninfectious in origin. Long-term, renal parenchymal injury may be associated with hypertension, pregnancy complications, proteinuria, and renal insufficiency. Optimal management of VUR and UTI is controversial because of the paucity of appropriate randomized controlled trials; there is a need for well-designed studies. The recently launched Randomized Intervention for children with VesicoUreteral Reflux (RIVUR) study hopefully will provide insight into the role of antimicrobial prophylaxis of UTI in children with VUR.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi V: Nursing Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations